Medannex announces Innovate UK grant award for novel cancer therapeutic development

Innovate UK, the UK’s innovation agency, has awarded Medannex £160,000 to boost the company’s oncology development programme. 

The Innovate UK Smart Grant will accelerate Medannex’s exploration of novel cancer therapeutics, in collaboration with ARU, Cambridge. 

Medannex has previously been awarded Innovate UK funding for ongoing investigations into new treatments for autoimmune diseases.

< BACK